Eisai, LIFENET to build ecosystem for reducing medical care burden in Japan

Eisai and LIFENET Insurance company have entered into a capital and business alliance agreement to collaborate in dement...

August 9, 2022 | Tuesday | News
Astellas Pharma puts forth new management structure

Astellas Pharma has announced the appintment of a new Chief Medical Officer (CMO)- Dr Tadaaki Taniguchi, as of...

August 8, 2022 | Monday | News
Grünenthal licenses-out osteoarthritis pain treatment to Shionogi in Japan

German firm Grünenthal and Japan-based Shionogi have entered into a licensing agreement for Grünenthal's inves...

August 4, 2022 | Thursday | News
Sosei Heptares and AbbVie enter new multi-target collaboration worth $1.2 B

Japanese firm Sosei Group Corporation and US-based AbbVie, a research-based global biopharmaceutical company, have enter...

August 3, 2022 | Wednesday | News
Japan approves Novavax's COVID-19 vaccine for adolescents

US-based Novavax has announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketi...

July 28, 2022 | Thursday | News
Shimadzu lays focus on diagnostic aid technology for depression using blood tests

Japan-based Shimadzu Corporation is participating in the project “Creating a System for Maintaining the Mental Hea...

July 26, 2022 | Tuesday | News
Shimadzu releases high-performance LCMS-2050

Japan-based Shimadzu Corporation has announced the release of the LCMS-2050 high-performance liquid chromatograph mass s...

June 11, 2022 | Saturday | News
Japan-based Astellas Pharma to open new biotech campus in US

Japan headquartered Astellas Pharma Inc. has announced plans to create an integrated biotechnology campus in S...

July 22, 2022 | Friday | News
Japanese startup Elix introduces 'all-in-one' platform for AI drug discovery

Japan-based startup Elix, Inc., an artificial intelligenet (AI) drug discovery company with the mission of “Rethin...

July 15, 2022 | Friday | News
Heidelberg Pharma inks deal worth € 105 M with Japan's Chiome Bioscience

Heidelberg Pharma AG and Japan-based Chiome Bioscience have announced the signing of an exclusive, target-specific resea...

July 18, 2022 | Monday | News
Aculys Pharma, SUSMED to conduct world's first clinical trial using blockchain

Japan-based Aculys Pharma has entered into a contract with SUSMED, Inc., a company that promotes digital medicine, to co...

July 13, 2022 | Wednesday | News
Japan-based 3D-printed prosthetic legs maker Instalimb raises ¥ 445 M

Japan-based world’s first 3D-printed prosthetic legs maker Instalimb raised 445 million yen (Rs 26 crore) in Serie...

July 13, 2022 | Wednesday | News
Fujitsu develops new technology for accurately estimating postures of human body

Japan-based Fujitsu has successfully developed a new technology to accurately estimate postures of the human body from c...

July 11, 2022 | Monday | News
Japan's Shionogi seeks China approval for COVID-19 treatment

Shionogi & Co., has announced that a joint venture between Shionogi and Ping An Life Insurance Company of China, , P...

July 8, 2022 | Friday | News
Eli Lilly Japan inks deal with Mitsubishi Tanabe for diabetes treatment

Eli Lilly Japan K.K. and Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a sales collaboration agreement in Japa...

July 7, 2022 | Thursday | News
Japan's Astellas Pharma partners with Mogrify to address sensorineural hearing loss

UK-based Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of i...

July 6, 2022 | Wednesday | News
Japan's EditForce & Mitsubishi ink gene therapy deal for ¥20 B

Japan-based EditForce has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to research,...

July 5, 2022 | Tuesday | News
Fujifilm invests $1.6 B to expand global offering of cell culture manufacturing services

Japan-based Fujifilm Corporation has announced the investment of $1.6 billion to enhance and expand the cell culture man...

July 4, 2022 | Monday | News